Urgent Care Centers lose $200 per patient if that Patient chooses a Retail Clinic and not YOUR URGENT CARE! The average generic copay for commercial insurance on Tier-1 Generics is $11-$12. You can sell many of these for a profit.


QCP’s Dispensing System is a perfect match for Urgent Care Centers.  Patients seek an Urgent Care clinic for fast, convenient and competent care that they can trust.  That is why they also choose to pick up their prescriptions in a convenient and confidential environment.

Point-of-Care Dispensing is one of the top 5 reasons patients visit a Retail clinic, your main competition!

Patients want to return because they save time and money, are treated personally and professionally in a feel-good way that says welcome back, and get well soon.  They also tell others about the one stop shop experience that almost seems too good to be true in the busy, fast pace world we live in today.

Read more at our article featured on Urgent Care Association’s blog.


QCP Response From CEO Mike Holmes To COVID-19

March 17, 2020


We have a unique responsibility to support our customers and their patients during this public healthcare crisis.

With a critical role supplying the pharmaceuticals urgently needed to respond to coronavirus, as well as to our pharmacies and clinics who dispense acute and chronic medications that their patients also need, QCP has held multiple meetings over the last few weeks to ensure that our customers needs are met in a safe and timely manner, and that our Employees stay safe and healthy.

No slowdown in service has occurred, and none is expected.

QCP’s office workers began working remotely from home last week and will continue to do so until the threat subsides. Workers at our healthcare repackaging, distribution and CSR center continue to report to work.

Thankfully, no employees have been diagnosed with COVID-19, the respiratory disease caused by the novel strain of the virus, and in fact only 1person has been diagnosed in all of Lucas County, at the time of this writing.

QCP has enacted a pre-established plan for responding to a pandemic based on guidelines passed down to us through our lobbying group, Healthcare Distributors Association, from the Centers for Disease Control and Prevention, and the U.S. Department of Health and Human Services, who view the role of QCP and other pharmaceutical Wholesalers as critical to the health and well-being of all Americans.

QCP’s goal has always been to maintain a 3-month supply of over 90% of its’ fast-moving pre-packaged medications. Still, in light of the pandemic, we have increased our supplies of multiple medications and, while we’ve experienced a slight increase in orders as some customers expect that supply chains could be interrupted, we’ve been able to maintain our inventory levels. To date, QCP has experienced zero issues, and the FDA said only 1 medication is in short-supply due to COVID 19. While the possibility of supply disruptions in the future exists, we are communicating with suppliers and customers, and will exhaust all efforts to mitigate any issues that may occur.